Cardan Capital Partners’s Eli Lilly LLY Stock Holding History

Cardan Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$666K	Buy	2,883 +27	+0.9%	+$6.66K	0.07%	141
2021 Q2	$656K	Hold	2,856	–	–	0.07%	147
2021 Q1	$534K	Sell	2,856 -600	-17%	-$117K	0.06%	148
2020 Q4	$584K	Hold	3,456	–	–	0.07%	133
2020 Q3	$512K	Hold	3,456	–	–	0.07%	144
2020 Q2	$567K	Buy	3,456 +158	+5%	+$24.3K	0.08%	135
2020 Q1	$457K	Buy	3,298 +292	+10%	+$40.1K	0.08%	130
2019 Q4	$395K	Hold	3,006	–	–	0.05%	146
2019 Q3	$336K	Sell	3,006 -68	-2%	-$7.57K	0.05%	157
2019 Q2	$341K	Buy	3,074 +68	+2%	+$8.01K	0.05%	141
2019 Q1	$390K	Sell	3,006 -1,029	-26%	-$125K	0.06%	130
2018 Q4	$467K	Hold	4,035	–	–	0.08%	114
2018 Q3	$433K	Hold	4,035	–	–	0.07%	135
2018 Q2	$344K	Sell	4,035 -73	-2%	-$6K	0.06%	143
2018 Q1	$318K	Buy	+4,108	New	+$331K	0.05%	146

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cardan Capital Partners's LLY Position: Q3 2021 in Review

Cardan Capital Partners increased its Eli Lilly (LLY) stake by 0.95% in Q3 2021, buying an estimated $6.66K and bringing the position to 2,883 shares worth $666K. The position accounts for 0.07% of the portfolio, ranked #141.

Cardan Capital Partners first reported a position in LLY in Q1 2018 and has held it in 15 quarters since. 2,050 funds tracked by Wall St. Rank hold LLY as of Q3 2021.

Cardan Capital Partners held 2,883 shares of Eli Lilly worth $666K as of Q3 2021.
Cardan Capital Partners bought 27 Eli Lilly shares in Q3 2021, an estimated $6.66K.
Eli Lilly made up 0.07% of Cardan Capital Partners's portfolio in Q3 2021, its #141 holding.
Cardan Capital Partners first reported a position in Eli Lilly in Q1 2018 and has held it in 15 quarters since.
2,050 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.

Based on Cardan Capital Partners's 13F filing for Q3 2021, filed 25 Oct 2021.